Cardiac Pathways' diagnostic catheter gets 510(k) clearance:
This article was originally published in Clinica
Executive Summary
The FDA has cleared Cardiac Pathways' Radii diagnostic catheter for performing single-point mapping procedures in patients with abnormally rapid heart rhythms, in particular supraventricular tachycardia. The catheter has a flexible, steerable shaft which allows it to reach various locations within the heart chamber and locate potential arrhythmia sites before treatment is applied.